bevacizumab drug pathway 2012-10-15T08:49:28Z PW:0001120 The pharmacokinetics and pharmacodynamics pathway of bevacizumab, a humanized monoclonal antibody that inhibits VEGF activity. It is used for the treatment of several types of advanced cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug. pathway vpetri monoclonal antibody drug pathway